Form 4: Columbia Financial, Inc. President & CEO Thomas J. Kemly Reports Acquisition of Common Stock
SEC Form 4 Filing
Thomas J. Kemly, President & CEO of Columbia Financial, Inc., reports the acquisition of common stock through a stock-based deferral plan.
Summary
- On May 2, 2025, Thomas J. Kemly, President & CEO of Columbia Financial, Inc., acquired 119.4606 shares of common stock at $14.96 per share through a stock-based deferral plan.
- Following the transaction, Kemly directly owns 233,808 shares and indirectly owns various shares through different plans and family members.
- Kemly also holds stock options to purchase 656,471 shares at $15.60 (fully vested), 37,894 shares at $15.94 (vesting from May 1, 2024), 37,168 shares at $16.49 (vesting from March 6, 2025), and 94,749 shares at $16.23 (vesting from March 3, 2026).
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The CEO's stock acquisition suggests confidence in the company, but it's a routine transaction.
Positives
- The CEO's continued investment in the company through stock acquisitions signals confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of stock options and awards indicate a long-term incentive structure.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's ongoing investment in the company, which can be viewed positively by investors.
Comparison to Industry Standards
- Comparing the vesting schedules and option exercise prices to similar financial institutions would provide a benchmark for the attractiveness of the compensation package.
- Companies like OceanFirst Financial Corp. and Northfield Bancorp, which operate in similar markets, could be used for comparison.
Stakeholder Impact
- The CEO's stock acquisition could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Date of grant for fully vested stock options with an exercise price of $15.60. |
| 05/01/2024 | Commencement date for vesting of stock options with an exercise price of $15.94. |
| 05/01/2024 | First vesting date for 25% of Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan. |
| 03/06/2025 | Commencement date for vesting of stock options with an exercise price of $16.49. |
| 03/06/2025 | First vesting date for 25% of Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan. |
| 05/02/2025 | Date of transaction: Acquisition of common stock through stock-based deferral plan. |
| 05/05/2025 | Date of Form 4 filing. |
| 03/03/2026 | Commencement date for vesting of stock options with an exercise price of $16.23. |
| 07/23/2029 | Expiration date for stock options with an exercise price of $15.60. |
| 05/01/2033 | Expiration date for stock options with an exercise price of $15.94. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
| 03/03/2035 | Expiration date for stock options with an exercise price of $16.23. |
Keywords
Form 4, Beneficial Ownership, Stock Options, Stock Awards, Columbia Financial, CLBK, Kemly, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.